BusinessAdamas Announces Publication of Amantadine Immediate Release Subgroup Analysis From EASE LID 2 Open-label Study in Movement Disorders Clinical PracticeBy Nasdaq OMXFeb 8, 2018, 2:01 PM UTC
BusinessAdamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis JournalBy Nasdaq OMXFeb 1, 2018, 9:05 PM UTC
BusinessAdamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA NeurologyBy Nasdaq OMXJun 12, 2017, 8:01 PM UTC
